
### [MONDO:0017182](http://purl.obolibrary.org/obo/MONDO_0017182)
**Label:** familial hyperinsulinism

**Subclasses:** [MONDO:0009278](http://purl.obolibrary.org/obo/MONDO_0009278) (hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), [MONDO:0011153](http://purl.obolibrary.org/obo/MONDO_0011153) (hyperinsulinemic hypoglycemia, familial, 2), [MONDO:0019265](http://purl.obolibrary.org/obo/MONDO_0019265) (Diazoxide-resistant focal hyperinsulinism), [MONDO:0019010](http://purl.obolibrary.org/obo/MONDO_0019010) (congenital isolated hyperinsulinism), [MONDO:0017186](http://purl.obolibrary.org/obo/MONDO_0017186) (Diazoxide-resistant hyperinsulinism), [MONDO:0015624](http://purl.obolibrary.org/obo/MONDO_0015624) (Diazoxide-sensitive diffuse hyperinsulinism), [MONDO:0015625](http://purl.obolibrary.org/obo/MONDO_0015625) (Diazoxide-resistant diffuse hyperinsulinism), 

**Corr. equiv. classes:** [Orphanet:165985](http://www.orpha.net/ORDO/Orphanet_165985), [OMIM:231530](http://purl.obolibrary.org/obo/OMIM_231530), [OMIM:601820](http://purl.obolibrary.org/obo/OMIM_601820), [Orphanet:165988](http://www.orpha.net/ORDO/Orphanet_165988), [Orphanet:657](http://www.orpha.net/ORDO/Orphanet_657), [Orphanet:71212](http://www.orpha.net/ORDO/Orphanet_71212), [Orphanet:276585](http://www.orpha.net/ORDO/Orphanet_276585), [Orphanet:79298](http://www.orpha.net/ORDO/Orphanet_79298), 

**Class expressions from DL-Learner:**

- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 53.32%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 53.32%
- [HP:0003117](http://purl.obolibrary.org/obo/HP_0003117) (Abnormality of circulating hormone level) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 53.32%
- [HP:0000842](http://purl.obolibrary.org/obo/HP_0000842) (Hyperinsulinemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 53.32%
- [HP:0000825](http://purl.obolibrary.org/obo/HP_0000825) (Hyperinsulinemic hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 53.32%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 53.32%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 53.32%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 53.32%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 53.32%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 53.32%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 53.32%
- [HP:0003117](http://purl.obolibrary.org/obo/HP_0003117) (Abnormality of circulating hormone level) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) 53.32%
- [HP:0003117](http://purl.obolibrary.org/obo/HP_0003117) (Abnormality of circulating hormone level) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) 53.32%
- [HP:0003117](http://purl.obolibrary.org/obo/HP_0003117) (Abnormality of circulating hormone level) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) 53.32%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 53.32%


